A large trial of screening pregnant women for Group B Streptococcus in late pregnancy or in labour will study its effect in reducing life-threatening infection in the newborn.
A large international study of ICP has identified a serum bile acid level below which there is no increase in the risk of stillbirth.
The early symptoms of myeloma are not very specific, but if a patient’s haemoglobin and plasma viscosity are both abnormal, this should prompt urgent blood and urine testing for the presence of abnormal proteins.
From early October NHS England will launch a new Genomic Medicine Service for routine care across the country by linking hospitals to specialist genomic centres.
This article , written by an NHS Pathologist, highlights the variety of work done in laboratories, and how it impacts on patient care. Approximately 70% of all diagnoses made in the NHS involve pathology and biomedical science.
Genetic testing of tumour tissue removed at during surgery may identify women with early breast cancer who do not need chemotherapy.
It has been known for some years that taking large doses of biotin can effect some lab test results.
A study of the risks and benefits of screening for prostate cancer with a prostate specific antigen (PSA) blood test, found that a group of 64,436 men aged 50 to 59 years followed for a mean of 10 years after a one-off blood test had the same death rate from the disease (0.29%) as a control group of men who did not have a PSA screening test performed.
A study from Sheffield University has shown that if a blood sample takes a long time to break down after clotting, there is an increased risk of a further heart attack, or death due to cardiovascular disease.